#75 Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
Clinicians need to be aware that pediatric cannabis poisonings represent a significant and growing poisoning risk, requiring prompt recognition of symptoms like altered mental status, ataxia, and bradycardia in young children who may have accessed edibles. Parents and caregivers should receive clear counseling about safe storage of cannabis products separate from food items, as edibles are particularly dangerous for young children who cannot distinguish them from regular candy or snacks. Emergency departments and primary care providers should maintain a low threshold for suspecting cannabis exposure in children presenting with unexplained neurological or cardiovascular symptoms, especially as cannabis legalization increases product availability in homes.
A 2025 analysis of Wisconsin Poison Center data reveals that 37% of cannabis poisoning calls involved children under 5 years old, with edible products accounting for the majority of pediatric exposures. The predominance of accidental ingestions in very young children underscores the accessibility of cannabis edibles in household settings and their appeal due to candy-like appearance and packaging. These exposures resulted in symptoms ranging from drowsiness and altered mental status to more serious effects including seizures and respiratory depression, with some cases requiring emergency department evaluation. The findings highlight a significant public health concern that clinicians should address during anticipatory guidance with cannabis-using parents and caregivers, particularly regarding secure storage of edible products away from children. Healthcare providers should maintain heightened awareness of cannabis toxicity as a differential diagnosis in young children presenting with altered consciousness, ataxia, or seizures, and should counsel patients that edibles pose particular risks due to delayed onset of effects and accidental overdose potential. Clinicians caring for families with cannabis use should implement explicit safety counseling about childproof storage, product labeling verification, and recognition of toxicity symptoms to prevent pediatric exposures.
“When we see edible cannabis products packaged indistinguishably from regular candy and placed on accessible shelves, we’re essentially conducting an uncontrolled experiment on our youngest patients, and the poison center data tells us exactly how that experiment is going. As clinicians, we need to advocate loudly for child-resistant packaging standards and clear labeling requirements, because counseling parents about accidental ingestion is reactive medicine when we should be preventing it entirely.”
🍃 The rising proportion of cannabis poisonings in young children reported to poison centers reflects both increased cannabis availability through legalization and the particular vulnerability of toddlers to accidental ingestion of edible products. Clinicians should recognize that pediatric cannabis exposures often present with nonspecific symptoms including lethargy, ataxia, tachycardia, and altered mental status, which may be mistaken for other acute illnesses or ingestions, creating diagnostic complexity. It is important to note that severe toxicity requiring intensive care is uncommon in children, and most cases resolve with supportive care, though cases have included seizures and respiratory depression warranting caution. Healthcare providers should routinely counsel caregivers and adolescent patients about secure storage of cannabis products separate from food items and educate them on recognizing signs of accidental exposure. When evaluating a young child with acute neurological or gastrointestinal symptoms, particularly in states
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it: